南平招聘

? Improving existing synthesis, finding alternative synthesis methods and scaling up of the lab process.
? Identifying and removing potential problems related to safety, ecology, industrial hygiene, robustness and economy which are associated with transforming a lab procedure into an manufacturing process.
? Elaborating lab procedures which are the basis of the final commercial production processes.
? Supporting the execution of new synthesis processes in the pilot plant.
? Synthesis of small amounts of (non GMP or GMP) drug substances, intermediates, reagents, by-products and degradation products, metabolites and other related compounds to support various drug development needs
? Active support of integrated technical development activities and work in interdisciplinary project team
? Contribute to continuous business improvements and participate in and/or manage minor projects/working groups to achieve the improvement objectives? Ph.D. in synthetic organic chemistry. Preferably PostDoc or equivalent experience in (pharmaceutical or chemical) industry, or master in synthetic organic chemistry with minimum 1 year pharmaceutical experience or equivelent.
? Proficient in MS office & Chemistry application software.
? Good interpersonal and communication skills
? Proactive and self-motivated
? Good organizational and planning skills
? Strong Team player
? Having good English language skills
? Mobile, and willing to relocate to Changshu or Suzhou

北京诺华制药有限公司开发、生产和销售治疗多种疾病的创新处方药，涵盖的疾病领域包括：心血管、内分泌、肿瘤、抗感染、风湿疼痛及骨质疏松、移植免疫、中枢神经以及眼科。北京诺华制药曾获得“***雇主”和“最负社会责任的企业”等殊荣。

“诺华”中文取意“承诺中华”，即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。北京诺华制药成立于1987年，总部设在北京，隶属于瑞士诺华公司。

诺华公司致力于为患者及社会提供创新医药保健解决方案，以满足其日益变化的健康需求。2011年，集团持续经营业务实现净销售586亿美元。集团研发投入约为96亿美元（去除减值及摊销后为92亿美元）。诺华集团总部位于瑞士巴塞尔，业务遍及全球140多个国家和地区，拥有124,000位全职员工。诺华集团立足在中国的长期发展，重要战略投资包括位于上海的综合性生物医学研发中心，以及位于北京昌平的制剂生产工厂和江苏常熟的原料药生产工厂。如需更多信息，敬请登录公司网站http://www.novartis.com和http://www.novartis.com.cn。